Multifunctionalized iron oxide nanoparticles for selective drug delivery to CD44-positive cancer cells

Nanotechnology

Volumn 27, Issue 6, 2016, Pages

  Aires, Antonio ^a,b   Ocampo, Sandra M ^a   Simões, Bruno M ^c   Josefa Rodríguez, María ^a,b   Cadenas, Jael F ^a   Couleaud, Pierre ^a,b   Spence, Katherine ^c   Latorre, Alfonso ^a,b   Miranda, Rodolfo ^a   Somoza, Álvaro ^a,b   Clarke, Robert B ^c   Carrascosa, José L ^a,b   Cortajarena, Aitziber L ^a,b  

^a INSTITUTO MADRILEÑO DE ESTUDIOS AVANZADOS EN NANOCIENCIA IMDEA NANOCIENCIA   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

active targeting; cancer; controlled drug release; magnetic nanoparticles; multifunctionalization; nanocarriers; nanomedicine

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; CYTOLOGY; DIAGNOSIS; DISEASES; DRUG PRODUCTS; IRON COMPOUNDS; IRON OXIDES; MEDICAL NANOTECHNOLOGY; NANOMAGNETICS; NANOPARTICLES; ONCOLOGY; STEM CELLS; SYNTHESIS (CHEMICAL);

ACTIVE TARGETING; CANCER; CONTROLLED DRUG RELEASE; MAGNETIC NANO-PARTICLES; MULTI-FUNCTIONALIZATION; NANO-CARRIERS;

CELLS;

DEOXYCYTIDINE; DRUG CARRIER; FERRIC ION; FERRIC OXIDE; GEMCITABINE; HERMES ANTIGEN; NANOPARTICLE;

ANALOGS AND DERIVATIVES; CANCER STEM CELL; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; MAGNETISM; MEDICINAL CHEMISTRY; METABOLISM; NANOMEDICINE; PHYSIOLOGY; PROCEDURES; TISSUE DISTRIBUTION; TUMOR CELL LINE; TUMOR EMBOLISM;

ANTIGENS, CD44; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DEOXYCYTIDINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; HUMANS; MAGNETICS; NANOMEDICINE; NANOPARTICLES; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; TISSUE DISTRIBUTION;

EID: 84954422969     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/27/6/065103     Document Type: Article

References (42)

1. Couvreur P 2013 Adv. Drug Deliv. Rev. 65 21-3
2. Mahmoudi M, Sant S, Wang B, Laurent S and Sen T 2011 Adv. Drug Deliv. Rev. 63 24-46
3. Cortajarena A L, Ortega D, Ocampo S M, Gonzalez-garcía A, Couleaud P, Miranda R, Belda-Iniesta C and Ayuso-Sacino A 2014 Nanobiomedicine 1 1-20
4. Jabr-Milane L S, van Vlerken L E, Yadav S and Amiji M M 2008 Cancer Treat. Rev. 34 592-602
5. Cho K, Wang X, Nie S, Chen Z G and Shin D M 2008 Clin. Cancer Res. 14 1310-6
6. Veiseh O, Gunn J W and Zhang M 2010 Adv. Drug Deliv. Rev. 62 284-304
7. Ravichandran R 2009 NanoBiotechnology 5 17-33
8. Naahidi S, Jafari M, Edalat F, Raymond K, Khademhosseini A and Chen P 2013 J. Control. Release 166 182-94
9. Krishnan K M 2010 IEEE Trans. Magn. 46 2523-58
10. Mejías R et al 2011 Biomaterials 32 2938-52
11. Salas G, Casado C, Teran F J, Miranda R, Serna C J and Morales M D P 2012 J. Mater. Chem. 22 21065-75
12. Pesarrodona M et al 2014 Int. J. Pharm. 473 286-95
13. Wang L et al 2012 Biomaterials 33 5107-14
14. Lee E, Hong Y, Choi J, Haam S, Suh J S, Huh Y M and Yang J 2012 Nanotechnology 23 465101-8
15. Baccelli I et al 2013 Nat. Biotechnol. 31 539-44
16. Sheridan C, Kishimoto H, Fuchs R K, Mehrotra S, Bhat-Nakshatri P, Turner C H, Goulet R Jr, Badve S and Nakshatri H 2006 Breast Cancer Res. 8 R59
17. Ponta H, Sherman L and Herrlich P A 2003 Nat. Rev. Mol. Cell Biol. 4 33-45
18. Zoller M 2011 Nat. Rev. Cancer 11 254-67
19. Al-Hajj M, Wicha M S, Benito-Hernandez A, Morrison S J and Clarke M F 2003 Proc. Natl Acad. Sci. USA 100 3983-8
20. Shipitsin M et al 2007 Cancer Cell. 11 259-73
21. Reya T, Morrison S J, Clarke M F and Weissman I L 2001 Nature 414 105-11
22. Peer D, Karp J M, Hong S, Farokhzad O C, Margalit R and Langer R 2007 Nat. Nanotechnol. 2 751-60
23. Goodison S, Urquidi V and Tarin D 1999 Mol. Pathol. 52 189-96
24. Gee K, Kryworuchko M and Kumar A 2004 Arch. Immunol. Ther. Exp. 52 13-26
25. Cardoso M M, Peça I N and Roque A C A 2012 Curr. Med. Chem. 19 3103-27
26. Dawidczyk C M, Kim C, Park J H, Russell L M, Lee K H, Pomper M G and Searson P C 2014 J. Control. Release 187 133-44
27. Yin T, Wei H, Gou S, Shi P, Yang Z, Zhao G and Wang C 2011 Int. J. Mol. Sci. 12 1595-604
28. Asuthkar S, Stepanova V, Lebedeva T, Holterman A L, Estes N, Cines D B, Rao J S and Gondi C S 2013 Mol. Biol. Cell. 24 2620-32
29. Ricardo S, Vieira A F, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro J F, Milanezi F, Schmitt F and Paredes J 2011 J. Clin. Pathol. 64 937-46
30. Dreaden E C, Morton S W, Shopsowitz K E, Choi J, Deng Z J, Cho N J and Hammond P T 2014 ACS Nano 8 8374-82
31. Latorre A, Couleaud P, Aires A, Cortajarena A L and Somoza A 2014 Eur. J. Med. Chem. 82 355-62
32. Marciello M, Connord V, Veintemillas-Verdaguer S, Vergés M A, Carrey J, Respaud M, Serna C J and Morales M P 2013 J. Mater. Chem. B 1 5995-6004
33. Creighton T E 1989 Disulfide bonds between cysteine residues Protein Structure: A Practical Approach ed T E Creighton (Oxford: IRL Press at Oxford University Press) pp 155-67
34. Bradford M M 1976 Anal. Biochem. 72 248-54
35. Chichón F J et al 2012 J. Struct. Biol. 177 202-11
36. Saito G, Swanson J and Lee K 2003 Adv. Drug Deliv. Rev. 55 199-215
37. Traut R R, Bollen A, Sun T T, Hershey J W, Sundberg J and Pierce L R 1973 Biochemistry 12 3266-73
38. Puertas S, Moros M, Fernández-Pacheco R, Ibarra M R, Grazú V and de la Fuente J M 2010 J. Phys. D. Appl. Phys. 43 474012-9
39. Hadjidemetriou M, Al-Ahmady Z, Mazza M, Collins R F, Dawson K and Kostarelos K 2015 ACS Nano 9 8142-56
40. Hermanson G T 2008 Bioconjugate Techniques 2nd edn ed Greg T Hermanson (New York: Academic) pp 793-5
41. Hirst J and Robinson M S 1998 Biochim. Biophys. Acta-Mol. Cell Res. 1404 173-93
42. Kirchhausen T 2000 Annu. Rev. Biochem. 69 699-727